Hospital Pharmaceuticals
Part of our work involves assisting District Health Boards with assessing and procuring pharmaceuticals used in public hospitals.
National Hospital Pharmaceutical Strategy
The National Hospital Pharmaceutical Strategy (64 pages, 172 KB) was developed in 2002 after DHBs asked PHARMAC to help them purchase hospital pharmaceuticals. The Strategy outlines PHARMAC's overall approach to purchasing hospital pharmaceuticals.
Section H of the Pharmaceutical Schedule (Hospital Pharmaceuticals)
Section H is the list of medicines that all DHB hospitals are required to fund. In addition, DHB hospitals can fund other medicines at their discretion (sometimes within defined limits). The first edition of Section H of the Pharmaceutical Schedule was published on 1 December 2002.
Click here to download the latest Section H.
Pharmaceutical Cancer Treatments
PHARMAC manages DHB hospital expenditure on Pharmaceutical Cancer Treatments (PCTs) through the Pharmaceutical Schedule from 1 July 2008. In addition to national contracting for these products, PHARMAC determines access criteria for PCTs. This means that patients around the country should have equivalent access at all DHB hospitals. DHBs are not able to provide access to treatment outside of the published list of PCTs, without an application under the Cancer Exceptional Circumstances process. This 
form can be downloaded.
Paediatric oncology/haematology does not have published national access criteria, and use of certain products may require notification for claims to be paid. Download (1 page, 39 KB) the notification form for Paediatric Oncology/Haematology
Hospital Pharmaceuticals Advisory Committee (HPAC)
The Hospital Pharmaceuticals Advisory Committee provides PHARMAC with advice on pharmaceuticals and other products used in DHB hospitals. You can read about the role and membership of the committee here.
Hospital Pharmaceutical Assessment Database
This database has been developed for those who work at District Health Board (DHB) Hospitals to provide you with access to cost-utility analyses and information on what pharmaceuticals are being assessed by DHBs and PHARMAC. We welcome any comments you have on these assessments.
Access the Hospital Pharmaceutical Assessment Database (HPAD).
Page updated on 10 Nov 2009
Linked documents
National Hospital Pharmaceutical Strategy (64 pages, 172 KB)
National Hospital Pharmaceutical Strategy Final Version Pharmaceutical Management Agency 1 February 2002 M16-3-8 #61114 1 Table of Contents Executive Summary 1.0 Introduction 2.0 Current Market Overview 2.1 Current purchasing arrangements 2.2 Range of pharmaceuticals purchased 2.3 Data collection and analysis…
Pharmaceutical Cancer Treatments Paediatric Oncology/Haematology Notification Form (1 page, 39 KB)
Pharmaceutical Cancer Treatments Paediatric Oncology/Haematology Notification Form Return completed form to: Exceptional Circumstances Panel Coordinator Phone: Fax: 04 916 7553 09 523 6870 Patient details Last name First name Date of birth NHI number Prescribing practitioner details Last name First…
